Clinical Trial Update: A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH [NA]

View source ↗

Summary

A clinical trial is evaluating Lasotronix alone or in combination with CPP-ACP for the treatment of dentin hypersensitivity and is currently recruiting at Dow U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• CPP-ACP (Casein phosphopeptide-amorphous calcium phosphate)
• Lasotronix

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Dentin Sensitivity, Hypersensitivity | NA | Status: RECRUITING